Author:
Wyde P R,Wilson S Z,Sun C S,Knight V
Abstract
Mice were inoculated intranasally with vesicular stomatitis virus 16 to 22 h after being exposed to small-particle aerosols of saline, natural mouse alpha interferon, recombinant human alpha interferon A, or hybrid recombinant human alpha interferon A/D bgl for 2, 4, or 8 h. Compared with comparably inoculated, untreated mice, significantly reduced levels of vesicular stomatitis virus were observed in the lungs of animals treated with any interferon preparation for 8 h and in groups treated with mouse alpha interferon or hybrid recombinant human alpha interferon A/D bgl for 4 h. No significant reductions in lung virus titers were observed in any group treated with interferon for 2 h or in any of the groups treated with saline.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference25 articles.
1. Clinical trials with exogenous interferon: summary of a meeting;Dunnick J. K.;J. Infect. Dis.,1979
2. Finter N. B. 1973. The assay and standardization of interferon and interferon inducers p. 135-361. In N. B. Finter (ed.) Interferons and interferon inducers 2nd ed. American Elsevier New York.
3. Prophylactic effect of low doses of human leukocyte interferon against infection with rhinovirus;Greenberg S. B.;J. Infect. Dis.,1982
4. Antiviral activity of intranasally applied human leukocyte interferon;Greenberg S. B.;Antimicrob. Agents Chemother.,1978
5. Measurement of the respiratory volumes of laboratory animals;Guyton A. C.;Am. J. Physiol.,1947
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献